A new study by University of Kentucky Markey Cancer Center researchers shows that chloroquine – a drug currently used to treat malaria – may be useful in treating patients with metastatic cancers. Published in Cell Reports, the study showed that chloroquine induced the secretion of the tumor suppressor protein Par-4 in both mouse models and in cancer patients in a clinical trial.

[from the VPR's Office]

University of Kentucky

Office of the Vice President for Research Equipment Competition

For applications submitted for due dates on or after January 25, 2017, text in PDF attachments must follow these minimum requirements:

Check out Newly Issued NIH Administrative Supplement Opportunities!

Although the continuing resolution for funding of the FY 2017 federal budget has been extended to spring, potentially delaying issuance of some awards or temporarily reducing current year budget amounts, the National Institutes of Health (NIH) has issued a number of opportunities for supplemental funding to an array of active awards across diverse grant mechanisms.  

Kentucky ranks eighth in the nation in our rate of stroke; we lose over 2000 Kentuckians every year to this disease. The risk factors are very similar to those for heart disease and include high blood pressure, diabetes, high cholesterol, smoking, obesity, and sedentary lifestyle. We can do a much better job preventing strokes if we understand what causes them. Dr.

Michele Staton-Tindall grew up in rural Appalachia during a time when people felt so safe they didn’t even lock their doors at night. The ensuing drug epidemic that now ravages her former home has dramatically impacted the lives of the Appalachian people and broken that sense of security.

Equestrian sports contributes to the highest percentage of traumatic brain injuries (TBI) in sports, based on findings in the National Trauma Databank.
Alan Daugherty, senior associate dean for research at the University of Kentucky College of Medicine, was recently approved to renew his contract as editor-in-chief of Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association (ATVB) for a second five-year term. ATVB is one of the five core journals of the American Heart Association. As editor of ATVB, Daugherty’s primary focus is on publishing the most important new research studies related to a spectrum of vascular diseases.

Eric Boodman

December 21, 2016 | STAT

"The medicines were rich and strange, their active ingredients so particular they sounded fictional..."

"Together, they envisioned a conference that would combine neuroscience, agriculture, history, nutrition, medicine, and cooking — to understand the art and science of why we eat what we eat, and how we could change it for the better."